UCLA platform bioprints mini tumors to test cancer drugs faster
UCLA Health researchers bioprint tiny replicas of patients' tumors, called organoids, and track how each one responds to drugs using dye-free imaging. AI follows every organoid individually, so the team can screen hundreds of possible therapies at once and see exactly which tumors respond. The method, described in Nature Protocols, could eventually help match treatments to a patient's own cancer cells.